Table 1 Participant characteristics
From: Facilitators, barriers and support needs to GLA:D exercise adherence – a mixed method study
Qualitative Phase | |||
|---|---|---|---|
All participants | Single interview | Focus group | |
(n = 11) | (n = 3) | (n = 8) | |
Age, years, mean (SD) | 64 (± 9.3) | 60 (± 7.6) | 66 (± 9.8) |
Gender, n (%) | |||
Women | 6 (55) | 2 (66) | 4 (50) |
Men | 5 (45) | 1 (33) | 4 (50) |
Joint(s) with OA, n (%) | |||
Knee(s) | 9 (82) | 3 (100) | 6 (75) |
Hip(s) | 2 (18) | 0 | 2 (25) |
Working, n (%) | |||
Yes | 6 (55) | 2 (66) | 4 (50) |
No | 5 (45) | 1 (33) | 4 (50) |
Quantitative Phase | |||
|---|---|---|---|
All participants | GE-adherent | GE-non-adherent | |
(n = 339) | (n = 178 (53%) | (n = 161 (47%) | |
Age, years, mean (± SD) | 67 (± 9.3) | 68 (± 8.1) | 65 (± 10.2) |
Women, n (%) | 227 (67) | 120 (67) | 107 (66) |
Highest level of education, n (%) | |||
mandatory school completed | 12 (4) | 6 (3) | 6 (4) |
secondary level | 181 (53) | 103 (58) | 78 (48) |
tertiary level | 146 (43) | 69 (39) | 77 (48) |
Employment status, n (%) | |||
employed 80–100% | 55 (16) | 21 (12) | 34 (21) |
employed 50–79% | 28 (8) | 13 (7) | 15 (9) |
employed less than 50% | 40 (12) | 18 (10) | 22 (14) |
unemployed | 216 (64) | 126 (71) | 90 (56) |
Years since OA diagnosis, n (%) | |||
less than 1 year | 16 (5) | 8 (4) | 8 (5) |
1 to < 3 years | 117 (35) | 65 (37) | 52 (32) |
3 to < 5 years | 77 (23) | 42 (24) | 35 (22) |
5 to < 10 years | 48 (14) | 29 (16) | 19 (12) |
10 or more years | 68 (20) | 29 (16) | 39 (24) |
Don’t know | 13 (4) | 5 (3) | 8 (5) |
Joint(s) with OA, n (%) | |||
Hip(s) | 61 (18) | 28 (16) | 33 (20) |
Knee(s) | 226 (67) | 122 (69) | 104 (65) |
Hip(s) and knee(s) | 52 (15) | 28 (16) | 24 (15) |
Daily living limitation due to OA, n (%) | |||
Not at all | 36 (11) | 17 (10) | 19 (12) |
Somewhat | 261 (77) | 139 (78) | 122 (76) |
Strongly | 42 (12) | 22 (12) | 20 (12) |
Comorbidities, n (%) | |||
No comorbidities except knee OA/ hip OA | 197 (58) | 104 (58) | 93 (58) |
Diabetes | 16 (5) | 12 (7) | 4 (2) |
Cancer | 12 (4) | 5 (3) | 7 (4) |
Cardiovascular diseases | 43 (13) | 21 (12) | 22 (14) |
Respiratory disease | 18 (5) | 11 (6) | 7 (4) |
Musculoskeletal diseases | 60 (18) | 35 (20) | 25 (16) |
Others | 15 (4) | 4 (2) | 11 (7) |